Surgery Partners, Inc. (SGRY) Has Another Very Strong Trading Session

December 7, 2017 - By Darrin Black

The stock of Surgery Partners, Inc. (NASDAQ:SGRY) is a huge mover today! The stock increased 5.99% or $0.5 during the last trading session, reaching $8.85. About 418,984 shares traded. Surgery Partners, Inc. (NASDAQ:SGRY) has risen 53.68% since December 7, 2016 and is uptrending. It has outperformed by 36.98% the S&P500.
The move comes after 8 months positive chart setup for the $431.61M company. It was reported on Dec, 7 by Barchart.com. We have $9.65 PT which if reached, will make NASDAQ:SGRY worth $38.84 million more.

Analysts await Surgery Partners, Inc. (NASDAQ:SGRY) to report earnings on March, 8. They expect $0.13 earnings per share, down 31.58 % or $0.06 from last year’s $0.19 per share. SGRY’s profit will be $6.34 million for 17.02 P/E if the $0.13 EPS becomes a reality. After $-0.04 actual earnings per share reported by Surgery Partners, Inc. for the previous quarter, Wall Street now forecasts -425.00 % EPS growth.

Surgery Partners, Inc. (NASDAQ:SGRY) Ratings Coverage

Among 10 analysts covering Surgery Partners (NASDAQ:SGRY), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Surgery Partners had 29 analyst reports since October 26, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Wednesday, November 1. Stifel Nicolaus initiated Surgery Partners, Inc. (NASDAQ:SGRY) on Tuesday, October 27 with “Buy” rating. RBC Capital Markets maintained Surgery Partners, Inc. (NASDAQ:SGRY) on Thursday, August 10 with “Buy” rating. Citigroup maintained the shares of SGRY in report on Monday, November 13 with “Buy” rating. The stock of Surgery Partners, Inc. (NASDAQ:SGRY) earned “Hold” rating by KeyBanc Capital Markets on Wednesday, September 20. The stock has “Strong Buy” rating by Raymond James on Monday, October 26. The rating was maintained by Citigroup on Friday, August 11 with “Buy”. Goldman Sachs initiated the stock with “Neutral” rating in Monday, October 26 report. The rating was initiated by Citigroup with “Buy” on Monday, October 26. On Monday, October 9 the stock rating was maintained by Bank of America with “Buy”.

More notable recent Surgery Partners, Inc. (NASDAQ:SGRY) news were published by: Forbes.com which released: “Surgery Partners Stock Plummets After Q2 Results Hint At Integration Challenges” on August 10, 2017, also Nasdaq.com with their article: “Bain Capital Investors Llc Buys Surgery Partners Inc, Sells Acadia Healthcare …” published on November 20, 2017, Seekingalpha.com published: “Surgery Partners’ (SGRY) CEO Brett Roberts on Q2 2017 Results – Earnings Call …” on August 09, 2017. More interesting news about Surgery Partners, Inc. (NASDAQ:SGRY) were released by: Seekingalpha.com and their article: “Surgery Partners’ (SGRY) Management on Q3 2017 Results – Earnings Call Transcript” published on November 09, 2017 as well as Globenewswire.com‘s news article titled: “Surgery Partners, Inc. Announces Third Quarter 2017 Results” with publication date: November 08, 2017.

Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company has market cap of $431.61 million. The firm operates through three divisions: Surgical Facility Services, Ancillary Services, and Optical Services. It currently has negative earnings. The Company’s surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastrointestinal, general surgery, ophthalmology, orthopedics, and pain management.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.